Open Access
| Issue |
EPJ Web Conf.
Volume 357, 2026
International Conference on Advanced Materials and Characterization (ICAMC 2025)
|
|
|---|---|---|
| Article Number | 02007 | |
| Number of page(s) | 6 | |
| Section | Biological Materials | |
| DOI | https://doi.org/10.1051/epjconf/202635702007 | |
| Published online | 10 March 2026 | |
- Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 May-Jun;74(3):229–263. doi: 10.3322/caac.21834. Epub 2024 Apr 4. PMID: 38572751 [CrossRef] [PubMed] [Google Scholar]
- Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 2009 Mar;9(3):153–66. doi: 10.1038/nrc2602. PMID: 19238148. [Google Scholar]
- Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999 Jun 15;13(12):1501–12. doi: 10.1101/gad.13.12.1501. PMID: 10385618. [Google Scholar]
- Finn RS, Dering J, Conklin D, Kalous O, Cohen DJ, Desai AJ, Ginther C, Atefi M, Chen I, Fowst C, Los G, Slamon DJ. PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Breast Cancer Res. 2009;11(5):R77. doi: 10.1186/bcr2419. PMID: 19874578; PMCID: PMC2790859. [Google Scholar]
- Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, Sonke GS, Paluch-Shimon S, Campone M, Blackwell KL, André F, Winer EP, Janni W, Verma S, Conte P, Arteaga CL, Cameron DA, Petrakova K, Hart LL, Villanueva C, Chan A, Jakobsen E, Nusch A, Burdaeva O, Grischke EM, Alba E, Wist E, Marschner N, Favret AM, Yardley D, Bachelot T, Tseng LM, Blau S, Xuan F, Souami F, Miller M, Germa C, Hirawat S, O'Shaughnessy J. Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer. N Engl J Med. 2016 Nov 3;375(18):1738–1748. doi: 10.1056/NEJMoa1609709. Epub 2016 Oct 7. Erratum in: N Engl J Med. 2018 Dec 27;379(26):2582. doi: 10.1056/NEJMx180043. PMID: 27717303. [Google Scholar]
- Fosgerau K, Hoffmann T. Peptide therapeutics: current status and future directions. Drug Discov Today. 2015 Jan;20(1):122–8. doi: 10.1016/j.drudis.2014.10.003. Epub 2014 Oct 17. PMID: 25450771. [Google Scholar]
- Sirpu Natesh N, Arumugam M, Karanam G. Apoptotic role of marine sponge symbiont Bacillus subtilis NMK17 through the activation of caspase-3 in human breast cancer cell line. Mol Biol Rep. 2018 Dec;45(6):2641–2651. doi: 10.1007/s11033-018-4434-y. Epub 2018 Nov 9. PMID: 30414102. [Google Scholar]
- Karanam G, Arumugam MK. Potential anticancer effects of cyclo(-Pro-Tyr) against N-diethyl nitrosamine induced hepatocellular carcinoma in mouse through PI3K/AKT signaling. Environ Toxicol. 2022 Feb;37(2):256–269. doi: 10.1002/tox.23395. [Google Scholar]
- Karanam G, Arumugam MK. Reactive oxygen species generation and mitochondrial dysfunction for the initiation of apoptotic cell death in human hepatocellular carcinoma HepG2 cells by a cyclic dipeptide Cyclo(-Pro-Tyr). Mol Biol Rep. 2020 May;47(5):3347–3359. doi: 10.1007/s11033-020-05407-5 [Google Scholar]
- Sirpu Natesh N, Arumugam M, Karanam G. Apoptotic role of marine sponge symbiont Bacillus subtilis NMK17 through the activation of caspase-3 in human breast cancer cell line. Mol Biol Rep. 2018 Dec;45(6):2641–2651. doi: 10.1007/s11033-018-4434-y. [Google Scholar]
- Glaviano A, Singh SK, Lee EHC, Okina E, Lam HY, Carbone D, Reddy EP, O'Connor MJ, Koff A, Singh G, Stebbing J, Sethi G, Crasta KC, Diana P, Keyomarsi K, Yaffe MB, Wander SA, Bardia A, Kumar AP. Cell cycle dysregulation in cancer. Pharmacol Rev. 2025 Mar;77(2):100030. doi: 10.1016/j.pharmr.2024.100030 [Google Scholar]
- Zabihi M, Lotfi R, Yousefi AM, Bashash D. Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities. J Cancer Res Clin Oncol. 2023 Apr;149(4):1585–1606. doi: 10.1007/s00432-022-04135-6 [Google Scholar]
- Zhang X, Wang Q, Luo Y, Song M, Zhou Z, Zeng L et al (2021c) Cyclin-dependent kinase 15 upregulation is correlated with poor prognosis for patients with breast cancer. J Int Med Res 49(6):300060521999552. 10.1177/0300060521999552 [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.